Publication | Open Access
Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt/β-catenin signaling pathway
53
Citations
21
References
2017
Year
This study suggested that CASC2 may potentially serve as a valuable diagnostic and prognostic biomarker and a therapeutic target for glioma patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1